Inicia sesión Registrate Mi Biblioteca biblioteca abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

2022

11031 ARTíCULOS , VIENDO DEL 61 AL 75

PUBMED

Deciphering the enigmatic crosstalk between prostate cancer and Alzheimer's disease: A current update on molecular mechanisms and combination therapy

Poddar NK, Agarwal D, Agrawal Y, Wijayasinghe YS, Mukherjee A, Khan S.

Biochim Biophys Acta Mol Basis Dis. 2022 Nov 1;1868(11):166524. doi: 10.1016/j.bbadis.2022.166524. Epub 2022 Aug 17.

0

0

0

PUBMED

Acylhydrazones and Their Biological Activity: A Review

Socea LI, Barbuceanu SF, Pahontu EM, Dumitru AC, Nitulescu GM, Sfetea RC, Apostol TV.

Molecules. 2022 Dec 9;27(24):8719. doi: 10.3390/molecules27248719.

0

0

0

PUBMED

Inosine in Neurodegenerative Diseases: From the Bench to the Bedside

Basile MS, Bramanti P, Mazzon E.

Molecules. 2022 Jul 21;27(14):4644. doi: 10.3390/molecules27144644.

0

0

0

PUBMED

Brexpiprazole-Associated Pisa Syndrome (Pleurothotonus) in a Patient With Dementia

Nagai Y, Yamazaki T, Sugita T, Shibata N.

Clin Neuropharmacol. 2022 May-Jun 01;45(3):72-73. doi: 10.1097/WNF.0000000000000500. Epub 2022 Apr 14.

0

0

0

PUBMED

Diabetes and dementia: Clinical perspective, innovation, knowledge gaps

Savelieff MG, Chen KS, Elzinga SE, Feldman EL.

J Diabetes Complications. 2022 Nov;36(11):108333. doi: 10.1016/j.jdiacomp.2022.108333. Epub 2022 Oct 5.

0

0

0

PUBMED

Inhibition of Insulin Degrading Enzyme to Control Diabetes Mellitus and its Applications on some Other Chronic Disease: a Critical Review

Azam MS, Wahiduzzaman M, Reyad-Ul-Ferdous M, Islam MN, Roy M.

Pharm Res. 2022 Apr;39(4):611-629. doi: 10.1007/s11095-022-03237-7. Epub 2022 Apr 4.

0

0

0

PUBMED

Insights into the Explicit Protective Activity of Herbals in Management of Neurodegenerative and Cerebrovascular Disorders

Behl T, Makkar R, Sehgal A, Sharma N, Singh S, Albratty M, Najmi A, Meraya AM, Bungau SG.

Molecules. 2022 Aug 4;27(15):4970. doi: 10.3390/molecules27154970.

0

0

0

PUBMED

Neurobiological Promises of the Bitter Diterpene Lactone Andrographolide

Hossain R, Quispe C, Herrera-Bravo J, Beltrán JF, Islam MT, Shaheen S, Cruz-Martins N, Martorell M, Kumar M, Sharifi-Rad J, Ozdemir FA, Setzer WN, Alshehri MM, Calina D, Cho WC.

Oxid Med Cell Longev. 2022 Feb 1;2022:3079577. doi: 10.1155/2022/3079577. eCollection 2022.

0

0

0

PUBMED

Impacts of oxidants and antioxidants on the emergence and progression of Alzheimer's disease

Goshtasbi H, Pakchin PS, Movafeghi A, Barar J, Castejon AM, Omidian H, Omidi Y.

Neurochem Int. 2022 Feb;153:105268. doi: 10.1016/j.neuint.2021.105268. Epub 2021 Dec 23.

0

0

0

PUBMED

Chinese Herbal Medicine Adjusting Brain Microenvironment via Mediating Central Nervous System Lymphatic Drainage in Alzheimer's Disease

Zhou XB, Zhang YX, Zhou CX, Ma JJ.

Chin J Integr Med. 2022 Feb;28(2):176-184. doi: 10.1007/s11655-021-3342-5. Epub 2021 Nov 3.

0

0

0

PUBMED

Self-efficacy in controlling upsetting thoughts, but not positive gains, mediates the effects of benefit-finding group intervention for Alzheimer family caregivers

Cheng ST, Chan WC, Fung HH, Lam LCW.

Psychol Aging. 2022 Sep;37(6):766-775. doi: 10.1037/pag0000654. Epub 2021 Nov 29.

0

0

0

PUBMED

Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer's Disease

Dhapola R, Sarma P, Medhi B, Prakash A, Reddy DH.

Mol Neurobiol. 2022 Jan;59(1):535-555. doi: 10.1007/s12035-021-02612-6. Epub 2021 Nov 2.

0

0

0

PUBMED

The calcium-free form of atorvastatin inhibits amyloid-β(1-42) aggregation in vitro

Nedaei H, Rezaei-Ghaleh N, Giller K, Becker S, Karami L, Moosavi-Movahedi AA, Griesinger C, Saboury AA.

J Biol Chem. 2022 Mar;298(3):101662. doi: 10.1016/j.jbc.2022.101662. Epub 2022 Jan 30.

0

0

0

PUBMED

Dietary fish oil increases catalase activity in patients with probable Alzheimer's disease

Torres-Mendoza BMG, Ortiz GG, Sánchez-Romero L, Delgado-Lara DLC, García Martínez MT, Mireles-Ramírez MA, Cruz Serrano JA, Pacheco Moisés FP.

Nutr Hosp. 2022 Dec 20;39(6):1364-1368. doi: 10.20960/nh.04153.

0

0

0

PUBMED

Safety and efficacy of plasma transfusion from exercise-trained donors in patients with early Alzheimer's disease: protocol for the ExPlas study

Tari AR, Berg HH, Videm V, Bråthen G, White LR, Røsbjørgen RN, Scheffler K, Dalen H, Holte E, Haberg AK, Selbaek G, Lydersen S, Duezel E, Bergh S, Logan-Halvorsrud KR, Sando SB, Wisløff U.

BMJ Open. 2022 Sep 6;12(9):e056964. doi: 10.1136/bmjopen-2021-056964.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy